SCHEMBL4446206

SCHEMBL4446206

O=C(O)OC(=O)N(c1ccccc1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.61
ATM Q13315 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
NPSR1 Q6W5P4 3/20 0.56
CHRM3 P20309 5/20 0.49
CHRM4 P08173 4/20 0.49
KMT2A Q03164 4/20 0.47
ALDH1A1 P00352 3/20 0.47
HTT P42858 2/20 0.47
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.47
RAB9A P51151 1/20 0.47
CHRM1 P11229 4/20 0.46
CHRM5 P08912 3/20 0.46
CHRM2 P08172 2/20 0.44
TRPM8 Q7Z2W7 1/20 0.42
MEN1 O00255 3/20 0.42
PTGIR P43119 1/20 0.41
PTGDR Q13258 1/20 0.41
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2249324 0.91 L3MBTL1 (0.65) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL2249329 0.83 L3MBTL1 (0.57) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL28622565 0.79 TDP1 (0.53) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL5962493 0.79 TDP1 (0.53) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL5494234 0.79 L3MBTL1 (0.63) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL15518997 0.77 L3MBTL1 (0.61) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL15518608 0.77 L3MBTL1 (0.61) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL3276086 0.77 L3MBTL1 (0.61) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL6002286 0.77 L3MBTL1 (0.61) L3MBTL1ATMTDP1NPSR1CHRM3
SCHEMBL20336349 0.76 L3MBTL1 (0.92) L3MBTL1ATMTDP1NPSR1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118647-A1 ANALYSIS OF FUNCTIONAL FLUIDS USING A REDOX INDICATOR THE LUBRIZOL CORPORATION (US) 2009-11-18 EP claimed
WO-2008106412-A1 ANALYSIS OF FUNCTIONAL FLUIDS USING A REDOX INDICATOR THE LUBRIZOL CORPORATION (US) 2008-09-04 WO claimed
EP-0165592-A2 Antitumor agents Bristol-Myers Company (US) 1985-12-27 EP claimed
JP-1131159-A None JP disclosed
WO-2023150396-A1 DEVICES, METHODS AND KITS FOR DETECTING EXPLOSIVES AND ILLICIT DRUG SUBSTANCES TRACE EYE-D, LLC (US) 2023-08-10 WO disclosed
EP-2126551-A1 ANALYSIS OF FUNCTIONAL FLUIDS THE LUBRIZOL CORPORATION (US) 2009-12-02 EP disclosed
EP-2118647-A1 ANALYSIS OF FUNCTIONAL FLUIDS USING A REDOX INDICATOR THE LUBRIZOL CORPORATION (US) 2009-11-18 EP disclosed
WO-2008106412-A1 ANALYSIS OF FUNCTIONAL FLUIDS USING A REDOX INDICATOR THE LUBRIZOL CORPORATION (US) 2008-09-04 WO disclosed
WO-2008106337-A1 ANALYSIS OF FUNCTIONAL FLUIDS THE LUBRIZOL CORPORATION (US) 2008-09-04 WO disclosed
JP-H01131159-A PRODUCTION OF INTERMEDIATE USEFUL FOR PRODUCTION OF ACRIDINYLAMINOMETHANESULFONANILIDE DERIVATIVE BRISTOL MYERS CO 1989-05-24 JP disclosed
US-4575553-A 4'-(9-ACRIDINYLAMINO)-METHANESULFON-M-==ANISIDE BRISTOL-MYERS COMPANY (US) 1986-03-11 US disclosed
US-4575553-A 4'-(9-ACRIDINYLAMINO)-METHANESULFON-M-==ANISIDE BRISTOL-MYERS COMPANY (US) 1986-03-11 US disclosed
EP-0165592-A2 Antitumor agents Bristol-Myers Company (US) 1985-12-27 EP disclosed
US-4472582-A 3,5-Disubstituted-4'-(9-acridinylamino)-methane-sulfon-m-anisidide compounds having antitumor properties DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND (NZ) 1984-09-18 US disclosed
EP-0025705-B1 COMPOUNDS HAVING ANTITUMOUR PROPERTIES, PROCESS FOR THEIR PREPARATION, THESE COMPOUNDS FOR USE AS ANTITUMOUR AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND (NZ) 1983-06-22 EP disclosed
EP-0025705-A1 Compounds having antitumour properties, process for their preparation, these compounds for use as antitumour agents and pharmaceutical compositions containing them DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND (NZ) 1981-03-25 EP disclosed